Harry Glorikian joins 3D Signatures BAD

3D Signatures (TSX-V:DXD; OTCQB:TDSGF; FSE:3D0) has appointed Harry Glorikian to its business advisory board.

Mr. Glorikian has over 30 years of private and public company experience in the biomedical and life sciences industries. He is recognized as a global innovator with high-profile consulting, executive and board experience, and a focus for data driven medical diagnostics.

Mr. Glorikian’s recent experience includes roles as entrepreneur in residence to GE Ventures – New Business Creation Group and as a director of GeneNews (TSX:GEN). He also serves on the advisory board of Nucelis and Evidation Health. He is also a co-founder and an advisory board member of DrawBridge Health, a diagnostics startup launched with support from GE Ventures.

“With the addition of Harry Glorikian to the business advisory board, 3DS has gained tremendous insight into the development and commercialization of cutting-edge medical diagnostics,” Jason Flowerday, CEO of 3DS, said in a statement.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.